Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
Michalis Liontos,
Maria Kaparelou,
Emmanouil Karofylakis,
Dimitra Kavatha,
Andreas Mentis,
Flora Zagouri,
Evangelos Terpos,
Meletios-Athanasios Dimopoulos
Affiliations
Michalis Liontos
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece; Corresponding author.
Maria Kaparelou
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
Emmanouil Karofylakis
4th Department of Internal Medicine, University Hospital « Attikon », 1 Rimini Avenue, 12462 Haidari, Athens, Greece
Dimitra Kavatha
4th Department of Internal Medicine, University Hospital « Attikon », 1 Rimini Avenue, 12462 Haidari, Athens, Greece
Andreas Mentis
Laboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece
Flora Zagouri
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
Evangelos Terpos
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
Meletios-Athanasios Dimopoulos
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
